Physician

Rheumatology

Dr. Andrew L. Mermelstein, MD

Andrew L. Mermelstein works in the field of Rheumatology. He researched medicine at NYU School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification", "Fellow (FACR)" and "Fellow". Andrew L. Mermelstein is a published MD as well. He has 1 publication published. The latest was: Rituximab in the treatment of bullous systemic lupus erythematosus. He accepts all Medicare patients.

Publications

Rituximab in the treatment of bullous systemic Lupus erythematosus.

Schools

New York University School Of Medicine
University Of Pa Health System

Procedures Preformed

Joint Drainage
Myofascial Trigger Point Injection
Steroid Injection
Viscosupplementation With Hyaluronate

Conditions Treated

Achilles Tendinitis
Adhesive Capsulitis
Ankylosing Spondylitis
Arthritis
View All

Doctors Specialties

Rheumatology

Accepted Insurances

Awards

CMS Meaningful Use Stage 1 Certification
Fellow (FACR)
Fellow

Education

University of Pennsylvania Health System
NYU School of Medicine

Hospital

Abington ?

Drug Facts

NPI NUMBER		1215920335
NPPES Provider LastName		MERMELSTEIN
NPPES Provider FirstName		ANDREW
NPPES Provider ZIPCode		194011389
NPPES Provider State		PA
Specialty Description		Rheumatology
Total Claim Count		4584.0
Distinct Opioid Count		11.0
Opioid Claim Count		671.0
Percent Opioid Claims		14.64

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1215920335
Last Name Of The Provider	MERMELSTEIN
First Name Of The Provider	ANDREW
View All

Similar Doctors

	Dr. Robert A. Moidel, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kerry B. Stone, MD This Doctor is OpenDoctor Recommended.
	Dr. Farhan Tahir, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Daniel K. Norden, MD This Doctor is OpenDoctor Recommended.
	Dr. Suzanne B. Travers, MD This Doctor is OpenDoctor Recommended.